163 related articles for article (PubMed ID: 32731733)
1. Pidotimod in allergic diseases.
Manti S; Parisi GF; Papale M; Leonardi S
Minerva Pediatr; 2020 Oct; 72(5):358-363. PubMed ID: 32731733
[TBL] [Abstract][Full Text] [Related]
2. Pidotimod. A new biological response modifier. Introduction.
Maillard F
Arzneimittelforschung; 1994 Dec; 44(12A):1399-401. PubMed ID: 7857330
[No Abstract] [Full Text] [Related]
3. Immunomodulating activity of Pidotimod in children with Down syndrome.
Zuccotti GV; Mameli C; Trabattoni D; Beretta S; Biasin M; Guazzarotti L; Clerici M
J Biol Regul Homeost Agents; 2013; 27(1):253-8. PubMed ID: 23489705
[TBL] [Abstract][Full Text] [Related]
4. Pidotimod: the past and the present.
Zuccotti GV; Mameli C
Ital J Pediatr; 2013 Dec; 39():75. PubMed ID: 24314100
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Pidotimod use in treating allergic rhinitis in a pediatric population.
Brindisi G; Zicari AM; Schiavi L; Gori A; Conte MP; Marazzato M; De Castro G; Leonardi L; Duse M
Ital J Pediatr; 2020 Jul; 46(1):93. PubMed ID: 32635938
[TBL] [Abstract][Full Text] [Related]
6. Immune modulator pidotimod decreases the in vitro expression of CD30 in peripheral blood mononuclear cells of atopic asthmatic and normal children.
Gourgiotis D; Papadopoulos NG; Bossios A; Zamanis P; Saxoni-Papageorgiou P
J Asthma; 2004; 41(3):285-7. PubMed ID: 15260461
[TBL] [Abstract][Full Text] [Related]
7. Pidotimod: a reappraisal.
Riboldi P; Gerosa M; Meroni PL
Int J Immunopathol Pharmacol; 2009; 22(2):255-62. PubMed ID: 19505378
[TBL] [Abstract][Full Text] [Related]
8. Pidotimod exacerbates allergic pulmonary infection in an OVA mouse model of asthma.
Fu LQ; Li YL; Fu AK; Wu YP; Wang YY; Hu SL; Li WF
Mol Med Rep; 2017 Oct; 16(4):4151-4158. PubMed ID: 28731127
[TBL] [Abstract][Full Text] [Related]
9. [Pidotimod in recurring respiratory infection in children with allergic rhinitis, asthma, or both conditions].
Vargas Correa JB; Espinosa Morales S; Bolaños Ancona JC; Farfán Ale JA
Rev Alerg Mex; 2002; 49(2):27-32. PubMed ID: 12092522
[TBL] [Abstract][Full Text] [Related]
10. [Potentiation of the resistance to viral and bacterial infections after pidotimod administration in mice].
Marelli P; Lupetti A; Senesi S; Uslenghi C; Girardello R; Campa M
Drugs Exp Clin Res; 1993; 19 Suppl():15-21. PubMed ID: 8625778
[No Abstract] [Full Text] [Related]
11. Pidotimod enhanced the anti-growth effect of cisplatin on lung cancer in mice via promoting anti-tumor immune response.
Wu T; Cui J; Gao J; Zhou H; Li A; Guo W
Biochem Biophys Res Commun; 2020 Aug; 528(4):678-684. PubMed ID: 32513535
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in Clinical Allergy and Immunology.
Simon D
Int Arch Allergy Immunol; 2018; 177(4):324-333. PubMed ID: 30399611
[TBL] [Abstract][Full Text] [Related]
13. Sublingual surprise: a new variant of oral lichen planus.
Jin X; Hu T; Zhao X; Chen Q; Zeng X
Am J Med; 2014 Jan; 127(1):28-30. PubMed ID: 24384098
[No Abstract] [Full Text] [Related]
14. Pidotimod may prevent recurrent respiratory infections in children.
Licari A; De Amici M; Nigrisoli S; Marseglia A; Caimmi S; Artusio L; Marseglia GL
Minerva Pediatr; 2014 Oct; 66(5):363-7. PubMed ID: 25253184
[TBL] [Abstract][Full Text] [Related]
15. Pidotimod as add-on therapy in patients with pollen-induced allergic rhinitis and asthma and associated respiratory infections.
Marogna M; Ciprandi G
J Biol Regul Homeost Agents; 2021; 35(3):1053-1058. PubMed ID: 34134476
[No Abstract] [Full Text] [Related]
16. An update on biological therapies for pediatric allergic diseases.
Castagnoli R; De Filippo M; Votto M; Marseglia A; Montagna L; Marseglia GL; Licari A
Minerva Pediatr; 2020 Oct; 72(5):364-371. PubMed ID: 32686927
[TBL] [Abstract][Full Text] [Related]
17. Pidotimod for the prevention of acute respiratory infections in healthy children entering into daycare: A double blind randomized placebo-controlled study.
Mameli C; Pasinato A; Picca M; Bedogni G; Pisanelli S; Zuccotti GV;
Pharmacol Res; 2015 Jul; 97():79-83. PubMed ID: 25931316
[TBL] [Abstract][Full Text] [Related]
18. The in vitro effect of Pidotimod on some immune functions in cancer patients.
Di Renzo M; Pasqui AL; Bruni F; Saletti M; Bova G; Chiarion C; Girardello R; Ferrì P; Auteri A
Immunopharmacol Immunotoxicol; 1997 Feb; 19(1):37-51. PubMed ID: 9049658
[TBL] [Abstract][Full Text] [Related]
19. Prophylaxis with the novel immunomodulator pidotimod reduces the frequency and severity of upper respiratory tract infections in children with Down's syndrome.
La Mantia I; Grillo C; Mattina T; Zaccone P; Xiang M; Di Mauro M; Meroni PL; Nicoletti F
J Chemother; 1999 Apr; 11(2):126-30. PubMed ID: 10326743
[TBL] [Abstract][Full Text] [Related]
20. Can probiotics be used to treat allergic diseases?
Tang RB; Chang JK; Chen HL
J Chin Med Assoc; 2015 Mar; 78(3):154-7. PubMed ID: 25575754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
